The GLP-1 Weight Loss Revolution | Form Health CEO Evan Richardson

GLP-1 drugs such as Ozempic and Wegovy have transformed best practices for weight loss care and created an opportunity for digital health innovation. In this episode, Steve Kraus sits down with Evan Richardson, founder and CEO of Form Health, to discuss GLP-1s and the virtual medical weight loss care landscape.

We cover:

- How Form Health differentiates itself in the competitive weight care market

- The impact of GLP-1 medications and the challenges of drug shortages

- The role of compounding pharmacies and potential regulatory changes

- The importance of holistic care and patient adherence for sustainable weight loss

- Obesity treatment innovation and the future of healthcare

- Advice for aspiring healthcare entrepreneurs from his experiences at Castlight Health and Included Health

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.